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ressure ulcers continue to challenge 
clinicians on a daily basis and there 
is a huge industry focussed on 
preventing their occurrence, with both 
national and international initiatives 
devoted to prevention. In England, an 
enormous data set (Safety Thermometer) 
on pressure ulcers is collected on a monthly 
basis that breaks pressure ulcer occurrences 
down into ‘new’ and ‘old’ (or pre-existing) 
ulcers across myriad healthcare settings. 
Quite rightly, many health improvement 
activities have been initiated to drive down 
the occurrence of new ulcers, as across the 
world the mantra of harm-free care has 
risen to the top of healthcare organisation's 
strategic objectives. 
The failure to prevent a pressure ulcer 
is seen as patient harm, a ref lection on 
the quality of care delivered, and will 
result in a discussion at the highest level 
about the impact on the patient's quality 
of life, the impact on length of stay and, 
therefore, on use of resources (Hauck et 
al, 2017). Whole teams devote time to 
identifying a number to allocate to the 
damage (as if this makes any difference) 
and to pinpointing where the ‘lapses in 
care’ occurred. But in the midst of all of 
these activities, what happens to the poor 
patients who actually have the misfortune 
to develop a pressure ulcer? Does anyone 
know what happens to them? How much 
time and effort is devoted to ensure that 
that patients are on the right pathway of 
care and the appropriate resources are 
allocated to make sure the pressure ulcer 
heals in a timely manner? How often are 
patients followed up to see how long it 
takes for the pressure ulcer to heal or for 
someone to decide that they are not on a 
trajectory for healing? I would suspect that 
every tissue viability nurse in the country 
has a patient in his or her area that has had 
a pressure ulcer for more than 5 or even 10 
years. Is this acceptable? It cannot all be 
about non-concordance or exacerbation 
of pathology. How often do these patients 
get brought to the front of a list, get seen 
by a multidisciplinary team, referred to a 
surgeon — or even get a thorough review 
of medication and/or nutrition? When 
they do, unsurprisingly, many of them 
make considerable progress and even go 
on to heal. Pressure ulcers cost the NHS 
a staggering amount of money (Guest et 
al, 2017) and whilst prevention should 
be the primary goal, shouldn’t we also 
be as focussed on healing those that do 
occur in the most effective way possible? 
The profile of tissue viability in the UK is 
becoming higher. We are starting to see 
a high-level focus on the outcomes for 
patients with wounds generated in part to 
the woeful care described by Guest et al 
(2017) with patients not having appropriate 
assessments or a plan of care and failing to 
heal for many years. It would be wonderful 
to see the targets stretched to include 
not just prevention — but also healing. 
Jacqui Fletcher
1. Do you think there is insuffcient 
attention paid to the progress of 
patients once they actually develop 
a pressure ulcer as the focus is so 
firmly on prevention and recording 
of occurrence? 
PV: Yes. Despite significant investment 
in pressure ulcer prevention and 
an increasing understanding of the 
mechanisms involved in tissue and cellular 
damage, there has been little progress in 
the treatment of pressure ulcers once they 
occur. As published studies (Hopkins et al, 
2006; Bale et al, 2007) illustrate, pressure 
ulcers have a major impact on patients' 
daily life. The “Burden of Wounds” study 
(Guest et al, 2015; 2017) has highlighted 
both the long duration and cost of these 
wounds. These findings do not differ 
significantly from those reported in earlier 
studies by Dealey et al (2012) and Bennett 
et al (2004) and serve to illustrate how 
little has changed for the patient with a 
pressure ulcer in the last decade.
RS: I agree to a certain extent, as there 
is a great deal of focus on pressure ulcer 
prevention and the reporting of the 
occurrence of a pressure ulcer. On the 
other hand, there is also an emphasis on 
investigating pressure ulcer formation, the 
patient’s status and pressure ulcer-related 
outcomes in different contexts. There are 
some things that can be improved, such as 
a greater focus on category/grade 2 pressure 
ulcers and the development of more intense 
pressure ulcer-related treatment plans. 
SP: In my experience in primary care, I 
have not found this. I think there is more 
concern when a patient has developed 
a pressure ulcer than there used to be; 
especially if it is full thickness as the 
staff will be disappointed for the patient 
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concerned and that harm has occurred. 
They will also be questioning how this 
could have happened and whether the 
correct preventative plans had been in place. 
This might also be the result of knowing 
that there will be an investigation and a 
report, which will be reviewed by senior 
members of the organisation. Since 2012, 
when NHS Midlands and East started its 
ambition to reduce pressure ulcers to zero, 
they are reported much earlier, when they 
are still small or shallow. And although, 
initially, numbers of avoidable pressure 
ulcers were not reducing, we realised 
they were much less significant in terms 
of injury, as the preventative plans were 
improving and we were learning from our 
investigations. In addition, we measured 
healing rates for acquired full-thickness 
pressure ulcers for a CQUIN and this 
demonstrated that, unless the patients 
died, the majority were healing or had 
healed at checks at 40 and 80 days. The 
predominant theme now, resulting from 
investigations into full-thickness pressure 
ulcers last year, is failure to change care 
plans/equipment/reassess risk in response 
to patients' deteriorating conditions or 
not recognising subtle changes in patients' 
risk when they have chronic conditions — 
this is where insufficient attention seems 
to be paid. However, having worked in 
hospitals and with nursing homes, there 
is a danger that, if supplies are scare — for 
example pressure-relieving equipment, and 
penalities or negative reports may result due 
to a new pressure ulcer — then specialist 
equipment might be moved from a patient 
with an existing pressure ulcer to an at-risk 
patient for prevention. However, this does 
contravene care recommendations and the 
NMC's code of conduct. 
AV: The focus nationally is definitely on 
prevention of pressure ulcers, and this is 
justified as the elimination of avoidable 
pressure ulcers is essential. However in 
my opinion there will always be pressure 
ulcers developing as there will always 
be the patient that collapses at home, 
not known to any services, who sadly 
lays on the f loor waiting to be found and 
gets admitted to hospital with pressure 
damage. It is essential that healthcare 
staff are aware of the principles of wound 
assessment and management so they can 
deal with these wounds when they occur. 
In addition if a patient does develop a 
pressure ulcer whilst receiving care then 
the healthcare provider has a responsibility 
to ensure that staff know how to care for 
their skin integrity and improve it. It may 
be that a grade 2 pressure ulcer could be 
prevented from deterioration to a grade 
three if the right care and attention was 
paid to the patient. 
2. Do you think there have been any 
significant new developments in the 
treatment of pressure ulcers? 
PV: Many of the therapeutic tools necessary 
for successful pressure ulcer management 
already exist. It is not so much about 
developing new treatments as providing 
an effective service model that allows 
coordinated and integrated care delivery. 
Only in this way can appropriate patients 
benefit from the timely introduction of 
advanced wound care and regenerative 
tissue engineered products occur. There 
are basic questions we, as service providers 
need to address, if we are to improve patient 
outcomes. Can staff adequately assess 
wounds, correctly categorising pressure 
damage, develop appropriate treatment 
plans and recognise and respond to delayed 
healing? For example, Vowden and Vowden 
(2015) have demonstrated that patients 
with heel pressure ulcers rarely receive 
vascular assessment, appropriate foot care 
and orthotic support to help maintain their 
mobility and optimise healing potential. 
RS: There have been some key 
developments in the treatment of pressure 
ulcers, such as novel medical devices and 
research which informs treatment such a 
PURPOSE T and PRESSURE 2. However, 
it is too early at this point to establish 
their significance with regards to pressure 
ulcer prevention.
SP: In Nottingham, when patients 
developed a large stage 3 or 4 pressure 
ulcers, we would often use larvae for swift 
debridement followed by topical negative 
pressure, using bridging techniques on 
heels or sacral wounds where possible. We 
also investigated the use of novel wound 
treatments but nothing has been as effective 
as the aforementioned treatments, and so 
we did not pursue these further. Now we 
rarely see extensive pressure ulceration that 
requires such intensive treatment, which 
is why we were able to concentrate more 
on pressure mapping for prevention and 
treatment to ensure that the blood flow to 
the wound or skin is optimal. This new type 
of pressure-relieving equipment has become 
part our pressure ulcer management. Over 
the past few years, we have become much 
more vigilant in assessing patients for 
osteomyelitis, if their pressure ulcers are 
not healing, and requesting blood tests with 
X-rays. Nutritional assessment remains key 
to the treatment plan. In primary care, one 
need is to have offloading devices for heel 
ulcers that patients can safely mobilise in.
AV: There are a few things that are new in 
pressure ulcer prevention and management, 
namely the Scanning Electron Microscope 
(SEM) scanner that reports to be able to 
identify early skin changes on the patient's 
skin, this could be particularly helpful in 
emergency departments when patients 
are first admitted and could allow higher 
preventative care to be implemented if early 
signs of non-visible skin damage had been 
identified by the SEM scanner. There are 
some companies now who have developed 
casting techniques for heel pressure ulcer 
prevention and management. Formally only 
used in diabetic foot ulcer and fracture 
management, the technique involves 
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bespoke casts made to the exact shape 
of the patient's heel to provide pressure 
reduction. 
We have effectively used Veraflo VAC 
therapy for the management of patients 
with grade 3 and 4 pressure ulcers with 
good effect. It is particularly helpful at 
removing some slough, managing exudate 
and facilitating granulation tissue. Lastly, 
the ToTo bed springs to mind when I 
think of developments in pressure ulcer 
prevention and management. This bed can 
assist the caregiver in repositioning and is 
reported to be helpful in patients who are 
in pain and struggling with repositioning. 
Colleagues have reported success in 
healing significant pressure damage 
when using this piece of equipment in 
community settings.   
3. Do you believe we should set targets 
for delivering improved outcomes for 
patients once they have developed a 
pressure ulcer?
PV: Yes. The recently introduced CQUIN 
related to wound assessment, which has 
been highlighted in recent Wounds UK 
publications (White et al, 2016; Wounds 
UK, 2017), goes some way to do this but 
we need to improve patient and wound 
monitoring so that patients are not left 
languishing with non-healing wounds. 
Currently, no one person seems to be 
responsible for the care of these patients —
who is held to account if a pressure ulcer 
has not healed at 6 months or a year? 
RS: Yes, there should be some nationally 
set targets with realistic goals for 
improving clinical outcomes for patients 
with a pressure ulcer in acute and 
community settings. It is important that 
any nationally set targets are informed 
by the best available evidence, as well as 
the views of clinicians (who are expected 
to deliver these outcomes), other key 
stakeholders and patients. At present, 
many clinicians are measured on their 
face-to-face contact, which gives no 
indication of the quality of care that 
patients receive and the impact of this 
care on patients’ pressure ulcer-related 
outcomes. It is also important that any 
targets that are set at a national level 
for delivering improved pressure ulcer 
related outcomes are accompanied by 
an appropriate level of investment and 
resourcing to ensure that they can be 
consistently delivered.       
SP: Yes I do. I think for any wound type, 
we should have pathways of care with 
expected outcomes at set time periods, 
actions to take following best practice 
guidance and processes to follow with 
rigorous reevaluation. Holistic assessment 
and reassessment is key and in primary 
care some patients will not heal well, if 
al all, meaning that maintenance and 
preventing deterioration may be the 
final goal. Every patient has the right 
to be treated in accordance with best 
practice standards of care and be referred 
to to specialists dependent on the 
pathway. If the pathway is not followed, 
justifications need to made as to why, 
which must be non-discriminatory. Too 
much in healthcare is left to individuals 
to decide and the disparity in knowledge 
and experience between healthcare 
professionals is widely evident. Promoting 
patient involvement with treatment plans 
also needs to be included in such pathways 
and best interest assessment to provide 
care for patients who do not have the 
ability to decide for themselves. 
AV: Yes. We should have an objective 
that the current wound improves and 
also that no new pressure ulcers develop 
whilst patients are in our care. The 
current national drive is elimination 
of pressure ulcers and focusses more 
on reporting of numbers, however 
this doesn’t take into account the 
individual patient's objectives in regards 
to their wound and may not consider 
their priorities.  
4. How could we encourage a more 
multidisciplinary approach to treating 
patients with pressure ulcers? 
   
PV: While financial and organisational 
barriers to appropriate referrals exist, it 
is impossible to allow a patient to move 
freely through the healthcare system 
to receive truly multidisciplinary and 
multi-professional care. If pressure 
ulcer development ref lects care failure 
by institutions and their healthcare 
professionals, then patients with 
pressure ulcers should receive prioritised 
care aimed at rapidly restoring skin 
integrity and patient quality of life. This 
unfortunately is rarely the case as the 
healthcare system is not penalised in any 
way if healing is delayed.
RS: It would be good if there was more 
integration in health and social care 
teams across primary and secondary 
settings. This would help to foster greater 
multidisciplinary team working in relation 
to the care of patients that have pressure 
ulcers. In settings where integration has 
taken place, it has facilitated improved 
multidisciplinary team working, which 
has improved key element of patient care 
by expediting support for equipment/
mobility etc. 
SP: I think we have come quite far with 
this in our area, but perhaps not far 
enough. All our healthcare professionals 
— physio and occupational therapists, 
matrons, nurses, assistant practitioners 
and support workers for nursing and 
rehabilitation services — undertake 
pressure ulcer risk assessments and order 
pressure-relieving equipment to varying 
degrees, depending on their level of 
access to order. Competency training is 
in place for pressure risk assessment as 
-
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well as guidance for using the equipment. 
We developed many new services with 
different healthcare professionals, such 
as the independence pathway and urgent 
care teams. Some consist of only a few 
nurses and some include staff who initially 
did not think pressure ulcer prevention 
and skin checking was part of their role. 
This has been largely overcome now; 
however, non-nursing professionals, can be 
limited by their lack of experience when 
assessing skin, looking at skin damage, and 
understanding skin changes. As a general 
observation, they tend to underestimate 
the risks to patients, which has been 
evident in some root cause analysis 
investigations. Teams who look after 
patients in the short-term do not see the 
results of their treatment plans so cannot 
evaluate if they were successful or not. 
We have a multidisciplinary team with 
staff from tissue viability, infection control, 
physiotherapy, occupational therapy, 
dietetics and continence care. They have 
worked well together and have contributed 
to our Pressure Ulcer Prevention Handbook 
for staff. I think the roles of physiotherapist 
and occupational therapist are key to 
keep patients mobile, promote movement, 
facilitate specialist seating and functioning. 
However, restrictions due to contract 
specifications can limit progress, as 
referrals for patients without 'rehabilitation 
potential' need to be very specifically 
described. We would like better links with 
the the Wheelchair Service, which is not 
part of our organisation, but is used by 
some of our patients. Other hospitals may 
have better access to their local service. 
Occasionally, we have case conferences 
with GPs, another important group of 
healthcare professionals who need to be 
involved as well, particuarly when patients 
are not making progress or have multiple 
problems at home. 
AV: I think we need a public campaign 
to raise awareness of the importance of 
identifying early skin changes and how 
to prevent pressure ulcers. This could 
allow the harder-to-reach disciplines 
and the general public to have a wider 
understanding of everyone’s involvement. 
Discussions should already be occuring 
at board rounds, ward rounds and 
multidisciplinary meetings that should 
include pressure ulcer prevention and 
management. 
In our Trust, we are just about to launch 
our latest campaign specifically designed 
to target the multidisciplinary team 
called 'Keep on ASKIN what YOU can 
do to PREVENT PRESSURE ULCERS'. 
This campaign will educate staff on the 
six moments of pressure ulcer prevention 
when they can ask what they can do to 
reduce the risk of patients developing 
tissue damage.  W
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